Clinical Trial: Safety and Efficacy of GENOSS(R) DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158307) titled 'Safety and Efficacy of GENOSS(R) DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion' on Aug. 28.

Brief Summary: The GENOSS PCB-De Novo study aims to evaluate the long-term efficacy and safety of a paclitaxel-coated balloon catheter containing shellac and vitamin E excipients (Genoss(R) DCB) in patients with De novo small coronary artery disease.

Study Start Date: June 27, 2024

Study Type: OBSERVATIONAL

Condition: Coronary Artery Disease(CAD)

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Genoss Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....